What Most Women Aren't Being Told

You've probably heard that menopause will finally give you a break from migraine. A large population study following nearly 5,000 women says that's not the full story and for almost half of them, it just wasn't true.

The relationship between migraine and female hormones is one of the most clinically underappreciated areas in women's health. Migraine is three times more common in women than men, and that gap is almost entirely driven by hormonal biology. The good news is that there's a lot you can do about it, but most women aren't being told about their options.

The Hormone-Migraine Connection

Estrogen is the central player. When estrogen is high and stable (as during the second and third trimesters of pregnancy) migraine often quiets down significantly. When estrogen drops sharply or swings unpredictably, the migraine threshold drops and attacks become more likely.

The mechanism runs through a molecule called CGRP (calcitonin gene-related peptide) a pain-signaling protein released from the trigeminal nerve, the nerve system responsible for head and face pain. Stable estrogen suppresses CGRP activity. Falling or fluctuating estrogen allows it to surge, lowering the threshold for an attack.

Migraine Across a Woman's Life

Migraine doesn't behave the same way across a woman's life. It tracks hormonal biology at every stage, which means the clinical picture at 15 looks very different from the one at 50. Data from the Norwegian NOWAC study, which followed 4,825 women with a history of migraine, provides some of the clearest population-level picture we have of this life course.

Perimenopause: The Hard Stretch

Perimenopause typically spans two to eight years before the final menstrual period. During this window, ovarian function becomes increasingly erratic and estrogen levels don't just decline, they oscillate. Some months estrogen spikes, others it craters. This unpredictability is precisely what makes perimenopause so difficult for migraine management.

The Menopause Reality

The conventional message: "your migraines will get better after menopause"... is an oversimplification. For some women it's true. For nearly half, it's not.

Why doesn't migraine simply switch off at menopause? Because menopause (technically defined as 12 consecutive months without a menstrual period) is a marker, not a biological event. Ovarian function declines gradually. Estrogen doesn't drop to zero overnight. The NOWAC data showed a gradual decline in migraine prevalence with increasing time since the last menstrual period, rather than a sharp cutoff.

Migraine With vs. Without Aura

The two major subtypes of migraine behave differently across the hormonal lifespan, and this distinction matters both for prognosis and for treatment decisions...especially around hormone therapy.

The aura subtype distinction is also clinically important in older women because migraine aura without headache becomes more common with age - and its symptoms (visual disturbances, transient sensory changes, speech difficulties) can be mistaken for more serious neurological events. Both subtypes followed broadly similar patterns of cessation in the NOWAC cohort, but migraine with aura remains somewhat less closely coupled to reproductive hormone fluctuations throughout the lifespan.

HRT and Migraine: Clearing Up the Confusion

One of the most persistent and harmful myths in clinical practice is that women with migraine, especially migraine with aura, cannot take hormone replacement therapy. This is not what current evidence or menopause specialist guidance says.

This distinction is particularly important for women with migraine with aura, who carry a baseline elevated risk for ischemic stroke. Transdermal estradiol is associated with minimal, if any, increased stroke risk above a woman's background risk. The same cannot be said for oral preparations or combined hormonal contraceptives. Getting this right clinically is not a minor detail as it directly affects whether women with aura are unnecessarily denied effective treatment for menopausal symptoms.

Practical Guidance on Hormonal Management

Migraine Screening as a Women's Health Standard

A 2026 position statement from the American Headache Society makes the case explicitly: routine migraine screening should be part of standard preventive healthcare for women and girls, particularly from adolescence through menopause.

Despite being one of the most prevalent neurological conditions and the leading cause of disability in women under 50, migraine remains significantly underdiagnosed and undertreated. The AHS position is that diagnostic screening for migraine meets the criteria for population-level screening because the disease is prevalent, burdensome, and there are effective treatments that produce better outcomes when started earlier.

Key Takeaways

If your migraine has gotten worse going into perimenopause, that's biology, and it's manageable. If you're postmenopausal and still having attacks, you're not alone, and you're not out of options. Knowing your migraine type, tracking your symptoms across hormonal transitions, and having a real conversation with a provider who understands both migraine and menopause are the most important steps.